GI
ANAB icon

GAMMA Investing’s AnaptysBio ANAB Stock Holding History

GAMMA Investing’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.2K Buy
447
+5
+1% +$303 ﹤0.01% 2610
2026
Q1 		$24.5K Buy
442
+58
+15% +$3.12K ﹤0.01% 2618
2025
Q4 		$18.6K Buy
384
+35
+10% +$1.36K ﹤0.01% 2655
2025
Q3 		$10.7K Sell
349
-12
-3% -$275 ﹤0.01% 2852
2025
Q2 		$8.01K Buy
361
+33
+10% +$691 ﹤0.01% 2916
2025
Q1 		$6.1K Buy
+328
New +$5.47K ﹤0.01% 2999
2024
Q4 		– Sell
-40
Closed -$1.34K – 3782
2024
Q3 		$1.34K Buy
40
+4
+11% +$137 ﹤0.01% 3177
2024
Q2 		$902 Buy
36
+15
+71% +$349 ﹤0.01% 3083
2024
Q1 		$473 Buy
21
+6
+40% +$142 ﹤0.01% 3113
2023
Q4 		$354 Buy
+15
New +$259 ﹤0.01% 3027

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

GAMMA Investing's ANAB Position: Q2 2026 in Review

GAMMA Investing increased its AnaptysBio (ANAB) stake by 1.1% in Q2 2026, buying an estimated $303 and bringing the position to 447 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2610.

GAMMA Investing first reported a position in ANAB in Q4 2023 and has held it in 10 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • GAMMA Investing held 447 shares of AnaptysBio worth $30.2K as of Q2 2026.
  • GAMMA Investing bought 5 AnaptysBio shares in Q2 2026, an estimated $303.
  • AnaptysBio made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2610 holding.
  • GAMMA Investing first reported a position in AnaptysBio in Q4 2023 and has held it in 10 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.